Alexander Schramm

发表

Streamlining Quantitative Analysis of Long RNA Sequencing Reads

Sebastian Oeck, Alicia I Tüns, Sebastian Hurst, 2020, International journal of molecular sciences.

Mutational dynamics between primary and relapse neuroblastomas

Sven Rahmann, Barbara Hero, Christopher Schröder, 2015, Nature Genetics.

Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

Frank Speleman, Rogier Versteeg, Isabelle Janoueix-Lerosey, 2010, Clinical Cancer Research.

MYCN regulates oncogenic MicroRNAs in neuroblastoma

Birgit Samans, Holger Christiansen, Kathy Astrahantseff, 2007, International journal of cancer.

Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.

Rogier Versteeg, Kathy Astrahantseff, Alexander Schramm, 2005, Cancer letters.

STATISTICAL EVALUATION OF METHODS FOR THE ANALYSIS OF DYNAMIC PROTEIN EXPRESSION DATA FROM A TUMOR STUDY

Barbara Sitek, Kai Stühler, Klaus Jung, 2006 .

The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma.

Francis Impens, Kris Gevaert, Frank Speleman, 2010, Molecular cell.

ArrayCGH‐based classification of neuroblastoma into genomic subgroups

Frank Speleman, Björn Menten, Rogier Versteeg, 2007, Genes, chromosomes & cancer.

Meta-mining of Neuroblastoma and Neuroblast Gene Expression Profiles Reveals Candidate Therapeutic Compounds

Filip Pattyn, Frank Speleman, Tom Van Maerken, 2009, Clinical Cancer Research.

Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas

Roland Eils, Jürgen Eils, Michael Klenk, 2005, Oncogene.

Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma

Sven Rahmann, Tobias Marschall, Stefan Schreiber, 2010, Nucleic acids research.

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling

Roland Eils, Frank Berthold, Benedikt Brors, 2004 .

Imperfect protection: NEPA at 35 years.

Frank Speleman, Anne De Paepe, Jo Vandesompele, 2004, Genome Biology.

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling

Roland Eils, Benedikt Brors, Holger Christiansen, 2004, Oncogene.

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

Gudrun Schleiermacher, John M. Maris, Benedikt Brors, 2010, Clinical Cancer Research.

Translating Expression Profiling into a Clinically Feasible Test to Predict Neuroblastoma Outcome

Roland Eils, Lars Kaderali, Benedikt Brors, 2007, Clinical Cancer Research.

Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarrays.

Toshifumi Ozaki, Eberhard Korsching, Alexander Schramm, 2002, International journal of oncology.

Reanalysis of neuroblastoma expression profiling data using improved methodology and extended follow-up increases validity of outcome prediction.

Katharina Morik, Lars Kaderali, Ingo Mierswa, 2009, Cancer letters.